Shilajit and Beta-Blockers (Bisoprolol, Metoprolol, Nebivolol)
Leila WehrhahnUpdated:Key points at a glance:
Shilajit is a natural resin that contains a range of minerals. It may be discussed as a possible addition to blood pressure-lowering treatments such as beta blockers, including bisoprolol, metoprolol and nebivolol. This combination may increase the likelihood of dizziness, light-headedness or fainting. Direct clinical studies on interactions are currently lacking. A small study reported antioxidant effects, but no measurable improvement in blood vessel function. Medical advice, gradual introduction, separating the timing of intake, and close self-monitoring are recommended. Particular attention should be paid to products with verified quality.
Shilajit is a mineral-rich natural resin found in high alpine regions and is traditionally used in Ayurvedic practices. In food supplements, the fraction rich in fulvic acid is considered the main active component. Beta-blockers such as bisoprolol, metoprolol and nebivolol are established medicines commonly used in the management of high blood pressure and other cardiovascular conditions. This article outlines how shilajit could theoretically enhance the effects of beta-blockers, what kind of evidence is available, and how potential risks in everyday use may be reduced.
For more in-depth information on shilajit, see our articles on effects, interactions and side effects.
Shilajit may, in theory, complement the blood pressure-lowering effects of beta-blockers. This could increase the likelihood of dizziness and circulatory symptoms – particularly at the start of therapy.
Overview of shilajit and beta-blockers
Beta-1-selective beta-blockers lower blood pressure and heart rate and are widely used. A meta-analysis reports average reductions of around 10/8 mmHg in blood pressure and a heart rate reduction of about 11 beats per minute (1). Nebivolol additionally has nitric oxide (NO)-mediated vasodilatory properties, which go beyond pure beta-blockade (2). Shilajit is often discussed in relation to antioxidant and adaptogenic properties; however, robust clinical data are still limited.
Mechanism of the possible interaction
- Beta-blocker action: Bisoprolol and metoprolol primarily block cardiac β1-receptors and thereby contribute to a reduction in heart rate and blood pressure (1). Nebivolol combines β1-blockade with endothelium-dependent NO release, which promotes vasodilation (2).
- Shilajit potentials: The humic substances in shilajit (including fulvic acid) can, in vitro, influence NO signalling pathways and show antioxidant activity; in human studies, the cardiovascular relevance of these findings is not yet well established. A small randomised controlled trial (RCT) in older adults with high blood pressure reported a reduction in markers of oxidative stress, but no improvement in endothelial function or arterial stiffness within 30 days (3).
Consequence: In theory, shilajit could have an additive effect on the blood pressure-lowering properties of beta-blockers (particularly with nebivolol, due to NO effects), which might increase the likelihood of symptomatic low blood pressure (dizziness, light-headedness, orthostatic symptoms). Direct clinical interaction studies are not yet available.
🧪 Shilajit Compatibility Check
Find out if there are any known risk factors that could contraindicate taking Shilajit.
Question 1 of 8
Clinical evidence: What do studies indicate?
- Beta-blockers: There is strong evidence supporting their effects on reducing blood pressure and heart rate; a Cochrane review of 56 RCTs reported significant reductions (1).
- Shilajit + antihypertensive medicines: An RCT in older patients with high blood pressure (500 mg shilajit twice daily for 30 days, in addition to standard therapy) showed reduced oxidative stress markers, without measurable changes in endothelial function or arterial stiffness; no relevant adverse effects were reported (3).
- Shilajit alone: In an older study in healthy adults (2 g per day for 45 days), there were no significant changes in blood pressure and heart rate; lipid parameters improved (4). Extrapolation is limited due to the study design and quality.
Safety profile/quality: Shilajit products can vary considerably in composition; reports highlight differences in active constituents and the potential presence of heavy metals. A recent review emphasises the need for quality control and adherence to WHO/FDA limits (5).
There are no direct studies on shilajit combined with beta-blockers. One RCT in people with high blood pressure reported antioxidant effects but no vascular improvement within 30 days.
Shilajit Capsules
Risk assessment: How relevant is the interaction?
Severity: Usually considered mild to moderate, and potentially more noticeable with nebivolol (NO release) or higher beta-blocker doses. Possible symptoms include dizziness, fatigue, light-headedness, cold sweats, visual disturbances and, in some cases, fainting.
Likelihood: Probably low to moderate, as reliable human data demonstrating a blood pressure-lowering effect of shilajit are lacking. Nevertheless, due to possible additive influences on vascular tone and heart rate, caution is advisable, especially when starting the combination or during dose adjustments (1–3).
At-risk groups: Older adults, individuals with orthostatic hypotension, underweight or dehydrated individuals, and patients with a low baseline heart rate while taking beta-blockers.
Product quality: Use only purified shilajit products with a certificate of analysis; contamination (e.g. with heavy metals) is possible (5).
Practical recommendations: How to reduce potential risks
- Consult a doctor before starting: Especially with beta-blockers, an individual assessment is important (indication, dose, co-existing conditions).
- Slow introduction: If approved by a healthcare professional, begin with the lowest manufacturer-recommended dose and do not increase without medical advice.
- Consider timing: At the start of combination use, take shilajit at a different time of day (e.g. 3–4 hours after the beta-blocker) to reduce the chance of overlapping peak effects.
- Self-monitoring for 2–4 weeks: Measure blood pressure and heart rate morning and evening, both sitting and standing, and record values and any symptoms. Seek medical advice if your resting pulse is <55/min or systolic blood pressure is <100 mmHg.
- Warning signs: New-onset dizziness or light-headedness, blacking out or “grey-out” of vision, cold sweats, chest pain or shortness of breath should be assessed by a healthcare professional without delay.
- Avoid additional triggers: Excessive alcohol, saunas/heat exposure and sudden standing up; be cautious with other blood pressure-lowering agents (e.g. PDE‑5 inhibitors) on the same day.
- Quality & purity: Prefer standardised, purified products with test reports; avoid products of unclear origin (5).
| Active substance | Characteristics | Typical daily dose |
|---|---|---|
| Bisoprolol | β1-selective; lowers heart rate/blood pressure | 2.5–10 mg once daily (as prescribed by a doctor) |
| Metoprolol | β1-selective; lowers heart rate/blood pressure | Individual; depends on product and medical guidance |
| Nebivolol | β1-selective + NO-mediated vasodilation | 5–40 mg once daily (depending on titration) |
Note: Doses are for general orientation only and do not replace individual medical prescribing (1,2).
Only start after discussing with a doctor, introduce slowly, take at different times of day, record blood pressure/heart rate, take warning signs seriously, and pay attention to product quality.
Conclusion
The combination of shilajit and beta-blockers could theoretically contribute to stronger blood pressure-lowering effects and make circulatory symptoms more likely in some individuals. Robust interaction studies are not yet available; a small RCT in people with high blood pressure reported antioxidant effects but no short-term vascular improvements. Anyone considering shilajit alongside beta-blockers should do so only after medical advice, with slow dose introduction, separated timing of intake and close self-monitoring. Pay close attention to the purity and quality of the product.
Medical disclaimer
Important notice: This information does not replace professional medical advice. Always consult your doctor or pharmacist before taking shilajit together with beta-blockers (e.g. bisoprolol, metoprolol, nebivolol). Every individual may respond differently to food supplements and medicines.